Average Co-Inventor Count = 4.82
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Alnylam Pharmaceuticals, Inc. (20 from 444 patents)
2. US Government As Represented by the Secretary of the Army (4 from 8,684 patents)
3. The United States of America As Represented by the Army (1 from 3 patents)
4. Arbutus Biopharma Corporation (57 patents)
20 patents:
1. 12460206 - PCSK9 iRNA compositions and methods of use thereof
2. 11873491 - Complement component C5 iRNA compositions and methods of use thereof
3. 11866701 - Complement component C3 iRNA compositions and methods of use thereof
4. 11326166 - Xanthine dehydrogenase (XDH) iRNA compositions and methods of use thereof
5. 11186842 - Complement component iRNA compositions and methods of use thereof
6. 11162098 - Complement component C5 iRNA compositions and methods of use thereof
7. 10465194 - Complement component iRNA compositions and methods of use thereof
8. 10125369 - PCSK9 iRNA compositions and methods of use thereof
9. 9850488 - Complement component C5 iRNA compositions and methods of use thereof
10. 9701963 - Complement component C5 iRNA compositions and methods of use thereof
11. 9249415 - Complement component C5 iRNA compositions and methods of use thereof
12. 9187516 - Compositions and methods for inhibiting expression of a gene from the Ebola virus
13. 9127275 - Compositions and methods for inhibiting expression of klf-1 and bcl11a genes
14. 9029338 - Lipid formulated compositions and methods for inhibiting expression of a gene from the ebola virus
15. 8912316 - Compositions and methods for inhibiting expression of CD45 gene